Fast Assay for Pathogen Identification - Quasi-Experimental Intervention Study (FAPIC-QE)
Sponsor: AIT Austrian Institute of Technology GmbH
A NA clinical study on Bacteremia and Sepsis, this trial is completed. The trial is conducted by AIT Austrian Institute of Technology GmbH and has accumulated 5 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Nov 2020 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
-
Oct 2019 — Nov 2020 [monthly]
Recruiting NA
First recorded
Jul 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AIT Austrian Institute of Technology GmbH
- Axo Science
- BEE Robotics
- Claude Bernard University
- Hasselt University
- Jessa Hospital
- Molzym
- School of Medicine, University of Zagreb
- University of Warwick
For direct contact, visit the study record on ClinicalTrials.gov .